|
SAMD4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
3.975300E-04 |
| Normal-vs-Stage3 |
1.99840144432528E-15 |
| Normal-vs-Stage4 |
2.39750441721753E-11 |
| Stage1-vs-Stage2 |
1.360740E-03 |
| Stage1-vs-Stage3 |
4.658000E-01 |
| Stage1-vs-Stage4 |
9.301200E-01 |
| Stage2-vs-Stage3 |
1.570280E-02 |
| Stage2-vs-Stage4 |
5.679600E-03 |
| Stage3-vs-Stage4 |
5.382400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.538350E-03 |
| Normal-vs-Asian |
1.17719944903172E-10 |
| Caucasian-vs-AfricanAmerican |
3.453800E-01 |
| Caucasian-vs-Asian |
2.935800E-01 |
| AfricanAmerican-vs-Asian |
1.350980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.758620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.09929843006285E-11 |
| Normal-vs-Age(81-100Yrs) |
1.363570E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.778700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.261900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.710600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.547400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.045000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.932610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.603600E-01 |
| Classical-VS-Follicular |
4.47797354752311E-12 |
| Classical-VS-Other |
5.55309999999976E-05 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
5.87939999999731E-05 |
| Tall-VS-Other |
3.175700E-04 |
| Tall-VS-Normal |
2.78749999749195E-08 |
| Follicular-VS-Other |
4.085400E-01 |
| Follicular-VS-Normal |
3.93720000000375E-05 |
| Other-VS-Normal |
3.860500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
8.77664607656925E-12 |
| N0-vs-N1 |
5.110100E-02 |
|
|
